期刊文献+

葛根素亚微乳的制备及家兔体内药物动力学评价 被引量:4

Preparation and Pharmacokinetics of Puerarin Submicron Emulsion in Rabbits
下载PDF
导出
摘要 以复合物-相转变-高压乳化法制备葛根素亚微乳,检测其粒径、ζ电位、微粒形态和药物在亚微乳各相中的分布。以葛根素注射液为对照,评价该微乳在家兔体内的药物动力学。结果表明,制品平均粒径188.1nm,ζ电位(-29.1±1.3)mV;75.6%的葛根素分布在磷脂膜中。与葛根素注射液相比,其亚微乳的AUC、t1/2β增大,清除率减小。 Puerarin submicron emulsion was prepared by the complex-phase inversion-high pressure homogeneization technology. The particle size, ζ potential, morphology of submicron emulsion and drug distribution of the products were examined. The pharmacokinetic of puerarin submicron emulsion in rabbits were performed with puerarin injection as the control. The results showed that the mean diameter and ζ potential of submicron emulsion prepared were 188.1nm and (-29.1 ± 1.3)mV, respectively. The percentage of puerarin distributed in phospholipid membrane was 75.6 %. Compared with puerarin injection, the A UC and t1/2β of puerarin submicron emulsion increased, while the clearance rate of puerarin was decreased.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2007年第7期491-495,共5页 Chinese Journal of Pharmaceuticals
关键词 葛根素 亚微乳 复合物-相转变-高压乳匀法 药物动力学 puerarin submicron emulsion complex-phase inversion-high pressure homogeneization technology pharmacokinetics
  • 相关文献

参考文献12

  • 1杨国君,张龙生,范礼理.葛根素抗冠心病心绞痛疗效观察及对血栓素 A_2和前列环素的影响[J].中西医结合杂志,1990,10(2):82-84. 被引量:185
  • 2邓培媛,李群娜,朱玉珍,裴振峨,张俊,翟伟,张京航,闫伟,詹思延.葛根素注射剂不良反应及其影响因素分析[J].药物流行病学杂志,2005,14(1):14-17. 被引量:58
  • 3Sznitowska M,Janicki S,Dabrowska E,et al.Submicron emulsions as drug carriers.Studies on destabilization potential of various drugs[J].Eur J Pharm Sci,2001,12 (3):175-179.
  • 4Fernandez P,Andre V,Rieger J,et al.Nano-emulsion formation by emulsion phase inversion[J].Colloids Surf A:Physicochem Eng Aspects,2004,251(1-3):53-58.
  • 5李颖,潘卫三,陈士林,杨大坚,陈新滋,徐宏喜.葛根素磷脂复合物的制备及其固体分散体研究[J].中国药学杂志,2006,41(15):1162-1167. 被引量:41
  • 6Wang L-X,He H-B,Tang X,et al.Aless irritant norcantharidin lipid microspheres:formulation and drug distribution[J].Int J Pharm,2006,323 (1-2):161-167.
  • 7Han J,Washington C.Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability[J].Int J Pharm,2005,288 (2):263-271.
  • 8Watrobska-Swietlikowska D,Sznitowska M.Partitioning of parabens between phases of submicron emulsions stabilized with egg lecithin[J].Int J Pharm,2006,312 (1-2):174-178.
  • 9Kim S J,Choi HK,Lee YB.Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A O/W-emulsion in rats[J].Int J Pharm,2002,249 (1-2):149-156.
  • 10Akkar A,Muller RH.Intravenous itraconazole emulsions produced by SolEmuls technology[J].Eur J Pharm Biopharm,2003,56 (1):29-36.

二级参考文献16

  • 1叶世泰.药物变态反应[A].见:叶世泰.现代临床医学丛书-变态反应学[M].北京:科学出版社,1998.171.
  • 2朱玉珍 赵明辉 王玉 等.利福平中毒实验诊断及致病机制[J].北京大学学报:医学版,2001,33:42-45.
  • 3GABETTA E,BOMBAROELLI E,PIFFERL G.Complexes of flavanolignanes with phospholipids,preparation there of and associated pharmaceutical composition.Patent No,0209038[P].1987-01-21.
  • 4WUJM CHENDW ZHANGRH etal.The review of the pharmaceutical study on the natural active component—phospholipid complex[J].中国药学杂志,1998,33(1):9-11.
  • 5CHEN D C.Handbook of Chemical Standard Sample of Tradational Chinese Drug(中药化学对照品工作手册)[M].Beijing:ChinaMedico-Pharmaceutical Science and Technology Publishing House,2000.
  • 6BOMBARDELLI E,BIANCHETTI G.Pharmaceutical and cosmetic compositions containing complexes of flavanoligans with phospholipid.Patent No,0300282[P].1989-01-25.
  • 7BOMBARDELLI E,SPELTA M.Aging skin:protective effect of silymarin-phytosome[J].Fitoterapia,1991,62(2):115-119.
  • 8BI D Z.Pharmaceutics(药剂学)[M].Beijing:People's Medical Publishing House,1997.
  • 9朱秀媛,苏成业,李振华,岳天立,阎香珍,魏怀玲.葛根有效成分的代谢研究——Ⅲ.葛根素的代谢及其药代动力学分析[J]药学学报,1979(06).
  • 10施邑屏,黎燕斌,孙玲玲,冯青,李祖义.^(31)P核磁共振光谱及薄层色谱分析针剂大豆卵磷脂[J].分析化学,1991,19(7):733-736. 被引量:26

共引文献273

同被引文献59

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部